Neuroinflammation in Alzheimer's disease.
Neuroinflammation in Alzheimer's disease.
复制标题
DOI:
10.1016/s1474-4422(15)70016-5
复制
发表时间:
2015-04
期刊:
影响因子:
--
通讯作者:
Kummer MP
中科院分区:
文献类型:
--
作者:
Heneka MT;Carson MJ;El Khoury J;Landreth GE;Brosseron F;Feinstein DL;Jacobs AH;Wyss-Coray T;Vitorica J;Ransohoff RM;Herrup K;Frautschy SA;Finsen B;Brown GC;Verkhratsky A;Yamanaka K;Koistinaho J;Latz E;Halle A;Petzold GC;Town T;Morgan D;Shinohara ML;Perry VH;Holmes C;Bazan NG;Brooks DJ;Hunot S;Joseph B;Deigendesch N;Garaschuk O;Boddeke E;Dinarello CA;Breitner JC;Cole GM;Golenbock DT;Kummer MP
Increasing evidence suggests that Alzheimer's disease pathogenesis is not restricted to the neuronal compartment but strongly interacts with immunological mechanisms in the brain. Misfolded and aggregated proteins bind to pattern recognition receptors on micro- and astroglia and trigger an innate immune response, characterized by the release of inflammatory mediators, which contribute to disease progression and severity. Genome wide analysis suggests that several genes, which increase the risk for sporadic Alzheimer's disease en-code for factors that regulate glial clearance of misfolded proteins and the inflammatory reaction. External factors, including systemic inflammation and obesity are likely to interfere with the immunological processes of the brain and further promote disease progression. This re-view provides an overview on the current knowledge and focuses on the most recent and exciting findings. Modulation of risk factors and intervention with the described immune mechanisms are likely to lead to future preventive or therapeutic strategies for Alzheimer's disease.